Treatment methods that are used at Infinity Clinic arise from the large body scientific studies performed by our scientists. Starting from basic research approximately two decades ago our specialists developed unique methods of stem cell treatment protected by the patents and authored the book “Stem cells: Experiment, theory, Clinical applications.”
To keep leading positions in the field of stem cell therapy that has witnessed tremendous breakthroughs over the recent years, international communications with outstanding scientists is of the great importance. Thus, we consider participation in international conferences that bring together leading experts in the field of stem cells from around the world as one of the key elements of our development and success.
Recently group of our experts headed by the Chief Doctor of Infinity Clinic MD, PhD Yuriy Derpak has presented results of stem cell treatment of the Duchenne muscular dystrophy at the 11th Guangzhou International Conference on Stem Cell and Regenerative Medicine and the 6th Annual Conference of Chinese Society for Regenerative Cell Biology. Our work was selected for the publication in the proceedings of the conference.
Scientists of Infinity Clinic meet with their colleagues from the USA, China, Germany, United Kingdom, Australia, Israel, Spain, etc. After discussion of the current challenges in stem cell research and new promising strategies for disease treatment, our group was invited to the lunch with editors of the world leading scientific journals, such as: Nature Communications, Nature Cell Biology, Cell Research, Nature Protocols, etc.
In front of the poster presentation of the results of stem cell treatment of the Duchenne muscular dystrophy. From the right to the left: Chief Doctor of Infinity Clinic MD, PhD Yuriy Derpak, Editor of the Nature Communications PhD Robert Stephenson, Chief Science Officer of Infinity Clinic MD, PhD Anatoliy Maslyukov.
Senior editor of the Nature Cell Biology PhD Christine Webber during her talk at the conference has mentioned thаt less than 20% of the total number of publications that are submitted to these journals are pass through rigorous peer-review process and published.
Chief Science Officer of Infinity Clinic MD, PhD Anatoliy Maslyukov who is a co-author of the papers published in Nature Communications and Cell Research (published by the Nature Research on behalf of the Shanghai Institutes for Biological Sciences (Chinese Academy of Sciences) and is affiliated with the Chinese Society for Cell Biology) and the first-author of the paper published in Cell Calcium (peer-reviewed scientific journal published by Elsevier) joined informal discussion with PhD Christine Webber about high standards of scientific publishing.
This conference extended our knowledge of recent advances in the field of stem cells and opened new routes for collaboration with outstanding research laboratories of the Europe, Asia and the USA.
